Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcinosis | 6 | 2015 | 62 | 1.310 |
Why?
|
| Macrophage Colony-Stimulating Factor | 8 | 2020 | 13 | 1.150 |
Why?
|
| Arteriosclerosis | 7 | 2004 | 43 | 1.030 |
Why?
|
| Osteoclasts | 2 | 2015 | 28 | 0.660 |
Why?
|
| Carotid Artery Injuries | 1 | 2016 | 5 | 0.490 |
Why?
|
| Giant Cells | 1 | 2015 | 15 | 0.480 |
Why?
|
| Carotid Artery Diseases | 1 | 2015 | 26 | 0.460 |
Why?
|
| Macrophages | 5 | 2020 | 529 | 0.450 |
Why?
|
| Lipoproteins, LDL | 3 | 2011 | 67 | 0.450 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2020 | 140 | 0.450 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 95 | 0.340 |
Why?
|
| Estradiol | 1 | 2011 | 268 | 0.310 |
Why?
|
| Albuminuria | 3 | 2020 | 78 | 0.300 |
Why?
|
| C-Reactive Protein | 2 | 2020 | 167 | 0.290 |
Why?
|
| Arteries | 3 | 2004 | 81 | 0.290 |
Why?
|
| Coronary Vessels | 3 | 2005 | 92 | 0.280 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 1070 | 0.270 |
Why?
|
| Brachytherapy | 2 | 2004 | 11 | 0.240 |
Why?
|
| Lipoproteins | 1 | 2005 | 70 | 0.220 |
Why?
|
| Endocrine System | 1 | 2004 | 12 | 0.220 |
Why?
|
| Matrix Metalloproteinase 3 | 2 | 2004 | 16 | 0.210 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 163 | 0.200 |
Why?
|
| Coronary Restenosis | 2 | 2004 | 28 | 0.200 |
Why?
|
| Membrane Glycoproteins | 3 | 2015 | 224 | 0.200 |
Why?
|
| Mice | 13 | 2020 | 6644 | 0.190 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2005 | 465 | 0.190 |
Why?
|
| Inflammation Mediators | 2 | 2020 | 140 | 0.190 |
Why?
|
| Osteopetrosis | 2 | 2002 | 4 | 0.190 |
Why?
|
| Bone and Bones | 1 | 2003 | 114 | 0.190 |
Why?
|
| Angioplasty, Balloon | 1 | 2002 | 4 | 0.190 |
Why?
|
| Animals | 18 | 2020 | 16992 | 0.180 |
Why?
|
| Receptors, LDL | 2 | 2020 | 42 | 0.180 |
Why?
|
| Immunoblotting | 2 | 2016 | 181 | 0.170 |
Why?
|
| Cell Membrane | 1 | 2002 | 403 | 0.160 |
Why?
|
| Mice, Knockout | 4 | 2020 | 1035 | 0.160 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 91 | 0.160 |
Why?
|
| Monocytes | 4 | 2011 | 277 | 0.150 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 1596 | 0.150 |
Why?
|
| Diabetic Nephropathies | 1 | 2019 | 78 | 0.140 |
Why?
|
| Models, Biological | 1 | 2002 | 712 | 0.140 |
Why?
|
| Inflammation | 2 | 2003 | 758 | 0.140 |
Why?
|
| Atherosclerosis | 1 | 2020 | 169 | 0.140 |
Why?
|
| Endothelial Cells | 2 | 2020 | 329 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 458 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 1869 | 0.130 |
Why?
|
| Cells, Cultured | 5 | 2011 | 1621 | 0.130 |
Why?
|
| Male | 11 | 2020 | 23409 | 0.130 |
Why?
|
| Rabbits | 1 | 2016 | 278 | 0.120 |
Why?
|
| Humans | 15 | 2020 | 43102 | 0.110 |
Why?
|
| Cell Proliferation | 1 | 2020 | 1455 | 0.110 |
Why?
|
| Female | 8 | 2020 | 24698 | 0.100 |
Why?
|
| Kidney Failure, Chronic | 2 | 2014 | 242 | 0.100 |
Why?
|
| Diabetes Complications | 1 | 2014 | 102 | 0.100 |
Why?
|
| Apoptosis | 1 | 2020 | 1568 | 0.100 |
Why?
|
| Middle Aged | 5 | 2020 | 12222 | 0.100 |
Why?
|
| Aged | 4 | 2020 | 8214 | 0.090 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2011 | 5 | 0.090 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 51 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 760 | 0.090 |
Why?
|
| Free Radical Scavengers | 1 | 2011 | 64 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1766 | 0.080 |
Why?
|
| Receptors, Immunologic | 2 | 2004 | 73 | 0.080 |
Why?
|
| Acetylcysteine | 1 | 2011 | 57 | 0.080 |
Why?
|
| Apolipoproteins E | 3 | 2011 | 138 | 0.080 |
Why?
|
| Dietary Fats | 1 | 2011 | 117 | 0.080 |
Why?
|
| Fatty Liver | 1 | 2011 | 77 | 0.080 |
Why?
|
| Cell Differentiation | 3 | 2008 | 638 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2853 | 0.070 |
Why?
|
| Follistatin | 1 | 2008 | 28 | 0.070 |
Why?
|
| Muscle Development | 1 | 2008 | 51 | 0.070 |
Why?
|
| Rats | 1 | 2016 | 3735 | 0.070 |
Why?
|
| beta Catenin | 1 | 2008 | 78 | 0.070 |
Why?
|
| Androgens | 1 | 2008 | 106 | 0.070 |
Why?
|
| Receptors, Androgen | 1 | 2008 | 144 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 216 | 0.060 |
Why?
|
| Time Factors | 1 | 2011 | 1857 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2011 | 1003 | 0.060 |
Why?
|
| Nutrition Surveys | 2 | 2020 | 263 | 0.060 |
Why?
|
| Tunica Intima | 2 | 2004 | 22 | 0.060 |
Why?
|
| Radiography, Thoracic | 1 | 2005 | 12 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2005 | 48 | 0.060 |
Why?
|
| Methods | 1 | 2005 | 14 | 0.060 |
Why?
|
| Anion Exchange Resins | 1 | 2005 | 3 | 0.060 |
Why?
|
| Preservation, Biological | 1 | 2005 | 3 | 0.060 |
Why?
|
| Lipoproteins, VLDL | 1 | 2005 | 4 | 0.060 |
Why?
|
| Chromatography, Gel | 1 | 2005 | 51 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 1998 | 526 | 0.060 |
Why?
|
| Heart Transplantation | 1 | 2005 | 47 | 0.060 |
Why?
|
| Swine | 2 | 2004 | 212 | 0.060 |
Why?
|
| Lipoproteins, HDL | 1 | 2005 | 48 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 238 | 0.050 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 22 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2005 | 63 | 0.050 |
Why?
|
| Echocardiography | 1 | 2005 | 167 | 0.050 |
Why?
|
| Thromboplastin | 1 | 2004 | 6 | 0.050 |
Why?
|
| Molecular Biology | 1 | 2004 | 47 | 0.050 |
Why?
|
| Catheterization | 1 | 2004 | 22 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 146 | 0.050 |
Why?
|
| Bone Development | 1 | 2003 | 28 | 0.050 |
Why?
|
| Aorta | 2 | 2020 | 198 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2004 | 883 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2004 | 78 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2004 | 934 | 0.050 |
Why?
|
| Cholesterol | 1 | 2005 | 232 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2003 | 79 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 150 | 0.050 |
Why?
|
| Obesity | 1 | 2011 | 1151 | 0.050 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2002 | 4 | 0.050 |
Why?
|
| Macrophage Activation | 1 | 2002 | 61 | 0.050 |
Why?
|
| Catalysis | 1 | 2002 | 187 | 0.050 |
Why?
|
| RANK Ligand | 1 | 2002 | 19 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2003 | 245 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2002 | 462 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2002 | 77 | 0.040 |
Why?
|
| Cell Division | 1 | 2002 | 311 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2002 | 411 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 455 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2020 | 51 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 72 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 384 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2002 | 1271 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2020 | 127 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2003 | 549 | 0.040 |
Why?
|
| Cadherins | 1 | 2020 | 102 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2002 | 321 | 0.040 |
Why?
|
| Urinalysis | 1 | 2019 | 34 | 0.040 |
Why?
|
| Creatinine | 1 | 2019 | 102 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2020 | 2157 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 440 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 1998 | 34 | 0.040 |
Why?
|
| Homozygote | 1 | 1998 | 77 | 0.040 |
Why?
|
| Heterozygote | 1 | 1998 | 110 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 518 | 0.030 |
Why?
|
| Colony-Stimulating Factors | 2 | 1989 | 3 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2002 | 1604 | 0.030 |
Why?
|
| Adult | 3 | 2020 | 13872 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 863 | 0.030 |
Why?
|
| DNA | 2 | 1998 | 592 | 0.030 |
Why?
|
| Stem Cell Factor | 1 | 1996 | 8 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 1998 | 161 | 0.030 |
Why?
|
| Child | 1 | 2005 | 3443 | 0.030 |
Why?
|
| Sertoli Cells | 1 | 1996 | 43 | 0.030 |
Why?
|
| Mutation | 2 | 1998 | 1177 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 1078 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 1996 | 127 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1063 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 1998 | 561 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 147 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2008 | 383 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 3994 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 3156 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2011 | 19 | 0.020 |
Why?
|
| Selenomethionine | 1 | 2011 | 13 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2011 | 32 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 76 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 105 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2011 | 80 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 234 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 152 | 0.020 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1989 | 8 | 0.020 |
Why?
|
| Neurons | 1 | 1997 | 1263 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1989 | 30 | 0.020 |
Why?
|
| United States | 1 | 2020 | 5205 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 1997 | 1001 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2008 | 17 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2008 | 18 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 20 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2008 | 37 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 1989 | 201 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1998 | 43 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 296 | 0.020 |
Why?
|
| Transfection | 2 | 1998 | 532 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 436 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 386 | 0.020 |
Why?
|
| Base Sequence | 2 | 1998 | 983 | 0.010 |
Why?
|
| Growth Substances | 1 | 1985 | 16 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1998 | 1542 | 0.010 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2004 | 16 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2004 | 46 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 41 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2004 | 51 | 0.010 |
Why?
|
| Pyrophosphatases | 1 | 2004 | 8 | 0.010 |
Why?
|
| Tunica Media | 1 | 2004 | 15 | 0.010 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2004 | 18 | 0.010 |
Why?
|
| E-Selectin | 1 | 2004 | 23 | 0.010 |
Why?
|
| Coronary Thrombosis | 1 | 2004 | 7 | 0.010 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2004 | 35 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 2004 | 28 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 65 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 107 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2004 | 168 | 0.010 |
Why?
|
| Cell Line | 2 | 1998 | 1410 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2004 | 72 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 81 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2004 | 95 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2004 | 171 | 0.010 |
Why?
|
| Estrogen Receptor alpha | 1 | 2004 | 121 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2004 | 148 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 5080 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 183 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 213 | 0.010 |
Why?
|
| Lipids | 1 | 2004 | 256 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2004 | 263 | 0.010 |
Why?
|
| Phenotype | 1 | 2004 | 780 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2004 | 561 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2004 | 863 | 0.010 |
Why?
|
| Cell Extracts | 1 | 1998 | 16 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1998 | 109 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2004 | 539 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1998 | 173 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1997 | 32 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1996 | 19 | 0.010 |
Why?
|
| Reference Values | 1 | 1997 | 211 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1998 | 281 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1997 | 136 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1997 | 296 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1997 | 508 | 0.010 |
Why?
|
| Testosterone | 1 | 1996 | 211 | 0.010 |
Why?
|
| DNA Methylation | 1 | 1998 | 403 | 0.010 |
Why?
|
| NF-kappa B | 1 | 1997 | 358 | 0.010 |
Why?
|
| Gene Expression | 1 | 1996 | 701 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1989 | 15 | 0.000 |
Why?
|
| Gene Frequency | 1 | 1989 | 206 | 0.000 |
Why?
|
| Interleukin-3 | 1 | 1985 | 2 | 0.000 |
Why?
|
| Lymphokines | 1 | 1985 | 18 | 0.000 |
Why?
|
| Trypsin | 1 | 1985 | 40 | 0.000 |
Why?
|
| Protein Denaturation | 1 | 1985 | 41 | 0.000 |
Why?
|
| Carbohydrates | 1 | 1985 | 32 | 0.000 |
Why?
|
| Organic Chemicals | 1 | 1985 | 36 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1985 | 68 | 0.000 |
Why?
|
| Amino Acids | 1 | 1985 | 148 | 0.000 |
Why?
|
| Insulin | 1 | 1985 | 258 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1985 | 1180 | 0.000 |
Why?
|